Matt Campobasso serves as Enfusion's General Counsel and Corporate Secretary. Starting with Enfusion in 2020, Matt spends his time overseeing Enfusion’s legal operations, which involves securing the company’s interests and understanding and managing legal risk at all levels of the company, as well as both internal and external to our business. A firm believer in the ethos that a problem prevented is better than a problem solved, Matt is the primary legal adviser to Enfusion's business, including as to Enfusion's Board of Directors, Chief Executive Officer, and across executive leadership.
“Enfusion is unlike any other company that I have ever worked for or with. Our collective commitment to our clients, our shareholders, and to each other is what distinguishes us from our competitors and beyond. During my time here, I have yet to encounter an issue or problem that wasn’t capable of being solved through collaboration and critical thinking by the incredibly smart, committed, and creative professionals that I am proud to call my colleagues.”
Matt began his legal career as a criminal prosecutor. Following that, he spent 11 years at a global law firm, first as an Associate and then as a Partner, in the firm's complex commercial litigation practice group. Later he served as General Counsel for a private consulting firm that was eventually acquired by IBM.
Matt graduated from the University of Illinois Urbana-Champaign in May 2000 with a Bachelor of Science in Psychology. He received his Juris Doctorate from the University of Illinois Chicago School of Law in May 2006.
What is Matthew Campobasso's net worth?
The estimated net worth of Matthew Campobasso is at least $791,757.36 as of March 5th, 2025. Mr. Campobasso owns 70,946 shares of Enfusion stock worth more than $791,757 as of April 2nd. This net worth estimate does not reflect any other investments that Mr. Campobasso may own. Learn More about Matthew Campobasso's net worth.
How old is Matthew Campobasso?
Mr. Campobasso is currently 45 years old. There are 6 older executives and no younger executives at Enfusion. The oldest executive at Enfusion is Mr. Bradley Herring, Chief Financial Officer, who is 53 years old. Learn More on Matthew Campobasso's age.
How do I contact Matthew Campobasso?
Has Matthew Campobasso been buying or selling shares of Enfusion?
Matthew Campobasso has not been actively trading shares of Enfusion during the last ninety days. Most recently, Matthew Campobasso sold 1,695 shares of the business's stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $11.38, for a transaction totalling $19,289.10. Following the completion of the sale, the general counsel now directly owns 70,946 shares of the company's stock, valued at $807,365.48. Learn More on Matthew Campobasso's trading history.
Who are Enfusion's active insiders?
Are insiders buying or selling shares of Enfusion?
During the last twelve months, insiders at the sold shares 29 times. They sold a total of 160,582 shares worth more than $1,648,833.48. The most recent insider tranaction occured on March, 6th when CEO Oleg Movchan sold 11,452 shares worth more than $130,438.28. Insiders at Enfusion own 36.4% of the company.
Learn More about insider trades at Enfusion. Information on this page was last updated on 3/6/2025.
